Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor ...

Baxter Healthcare Corp.’s injectable drug for treating severely low blood pressure doesn’t literally infringe five Nevakar ...

Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

D EERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16.65 billion and annual revenue of $15.06 billion, announced today ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

Top-line performance in the fourth quarter exceeded Baxter’s previously announced guidance, driven by better-than-expected sales in the company’s Medical Products & Therapies and ...

Carla Baxter started her store, Baxter Beauty Supply, in November 2023 and will soon be moving the business to a new Redding ...

offset by select product/market exits. Guidance: Baxter expects 2025 adjusted EPS of $2.45-$2.55 versus consensus of $2.47, with sales growth of 5%-6% on a reported basis and 4%-5% on an organic ...

Baxter's Voalte platform is a unified digital care communications solution. The Linq device integrates with existing products in Baxter's connected care portfolio including Voalte mobile ...